Bioavailable capsule compositions of amorphous alpha- (N-sulfonamido)acetamide compound

Details for Australian Patent Application No. 2010236602 (hide)

Owner Bristol-Myers Squibb Company

Inventors Chandran, Sachin; Gandhi, Rajesh Babulal; Levons, Jaquan Kalani; Perrone, Robert Kevin; Price, Christopher P.; Raghavan, Krishnaswamy Srinivas; Ullah, Ismat

Agent A J Park

Pub. Number AU-A-2010236602

PCT Pub. Number WO2010/120755

Priority 61/169,061 14.04.09 US

Filing date 13 April 2010

Wipo publication date 21 October 2010

International Classifications

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 47/10 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Alcohols

Event Publications

13 October 2011 PCT application entered the National Phase

  PCT publication WO2010/120755 Priority application(s): WO2010/120755

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010236606-Interferon-alfa sensitivity biomarkers

2010236595-Soft fiber insulation product